Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway
Ning Zhang,1,* Tong Liu,1,* Jianan Wang,2,* Yingying Xiao,1 Ying Zhang,1 Jun Dai,1 Zhihong Ma,1,3 Donglai Ma4 1School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, 050200, People's Republic of China; 2Graduate School, Hebei University of C...
Saved in:
Main Authors: | Zhang N (Author), Liu T (Author), Wang J (Author), Xiao Y (Author), Zhang Y (Author), Dai J (Author), Ma Z (Author), Ma D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
by: Jun-Ke Long, et al.
Published: (2019) -
Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis
by: Siliang Wang, et al.
Published: (2021) -
Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism
by: Bin Li, et al.
Published: (2024) -
FGF9 Alleviates the Fatty Liver Phenotype by Regulating Hepatic Lipid Metabolism
by: Fanrong Zhao, et al.
Published: (2022) -
Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling
by: Jian Li, et al.
Published: (2018)